Phagocytosis: Reemerging roles for a primitive function

Plastic and Reconstructive Surgery

Volumn 123, Issue 3, 2009, Pages 834-847

  Krajewski, Aleksandra ^a   Garg, Manish ^a   De, Mithu ^a   Chandawarkar, Rajiv Y ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BETA CHEMOKINE; BETA GLUCAN; CALRETICULIN; CELL SURFACE RECEPTOR; CHEMOATTRACTANT; COLONY STIMULATING FACTOR 1; CONCANAVALIN A; HEAT SHOCK PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NANOPARTICLE; PLATELET DERIVED GROWTH FACTOR; RANTES; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; AGING; ANTIBIOTIC RESISTANCE; ANTIGEN PRESENTATION; BURN; CELL MATURATION; CELL MIGRATION; CELL VACUOLE; CONFOCAL MICROSCOPY; DENDRITIC CELL; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; GENETIC ENGINEERING; HISTOCOMPATIBILITY; HUMAN; INFECTION; INNATE IMMUNITY; KELOID; MACROPHAGE; MELANOMA; MICROARRAY ANALYSIS; NEUTROPHIL; PHAGOCYTOSIS; PHAGOSOME; PLASTIC SURGERY; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEOMICS; REGENERATIVE MEDICINE; REVIEW; SKIN CANCER; STEM CELL; TISSUE REGENERATION; WOUND HEALING;

ANIMALS; HUMANS; PHAGOCYTOSIS; RECONSTRUCTIVE SURGICAL PROCEDURES;

EID: 67651207546     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e318199f01d     Document Type: Review

References (73)

1. Desjardins M, Houde M, Gagnon E. Phagocytosis: The convoluted way from nutrition to adaptive immunity. Immunol Rev. 2005;207:158-165.
2. Reiling J. The coming of age of phagocytosis. JAMA. 2006; 295:337.
3. Shaw GB. The Doctor's Dilemma : New York: Penguin; 1911.
4. O'Neill LA. TLRs: Professor Mechnikov, sit on your hat. Trends Immunol. 2004;25:687-693.
5. van Kooyk Y, Geijtenbeek TB. Toll-like receptors keep antigen sorting on the right track. Immunity 2006;25:525-527.
6. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987;329:512-518.
7. Hedrick SM, Cohen DI, Nielsen EA, Davis MM. Isolation of cDNA clones encoding T cell-specific membrane-associated proteins. Nature 1984;308:149-153.
8. Finlay BB, McFadden G. Anti-immunology: Evasion of the host immune system by bacterial and viral pathogens. Cell 2006;124:767-782.
9. Djaldetti M, Salman H, Bergman M, Djaldetti R, Bessler H. Phagocytosis: The mighty weapon of the silent warriors. Mi-crosc Res Tech. 2002;57:421-431.
10. Henneke P, Golenbock DT. Phagocytosis, innate immunity, and host-pathogen specificity. J Exp Med. 2004;199:1-4.
11. Savina A, Amigorena S. Phagocytosis and antigen presentation in dendritic cells. Immunol Rev. 2007;219:143-156.
12. Stuart LM, Ezekowitz RA. Phagocytosis: Elegant complexity. Immunity 2005;22:539-550.
13. Underhill DM, Ozinsky A. Phagocytosis of microbes: Complexity in action. Annu Rev Immunol. 2002;20:825-852.
14. DiPietro LA. Wound healing: The role of the macrophage and other immune cells. Shock 1995;4:233-240.
15. DiPietro LA, Burdick M, Low QE, Kunkel SL, Strieter RM. MIP-1alpha as a critical macrophage chemoattractant in mu-rine wound repair. J Clin Invest. 1998;101:1693-1698.
16. Pierce GF, Mustoe TA, Lingelbach J, et al. Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol. 1989;109:429-440.
17. Tanaka E, Ase K, Okuda T, Okumura M, Nogimori K. Mechanism of acceleration of wound healing by basic fibroblast growth factor in genetically diabetic mice. Biol Pharm Bull. 1996;19:1141-1148.
18. Witte MB, Barbul A. General principles of wound healing. Surg Clin North Am. 1997;77:509-528.
19. Dipietro LA, Reintjes MG, Low QE, Levi B, Gamelli RL. Modulation of macrophage recruitment into wounds by monocyte chemoattractant protein-1. Wound Repair Regen. 2001;9:28-33.
20. Lehner T, Bergmeier LA, Wang Y, et al. Heat shock proteins generate beta-chemokines which function as innate adjuvants enhancing adaptive immunity. Eur J Immunol. 2000;30: 594-603.
21. Asea A, Kraeft SK, Kurt-Jones EA, et al. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med. 2000;6:435-442.
22. Tsan MF, Gao B. Heat shock protein and innate immunity. Cell Mol Immunol. 2004;1:274-279.
23. Wallin RP, Lundqvist A, Moré SH, von Bonin A, Kiessling R, Ljunggren HG. Heat-shock proteins as activators of the innate immune system. Trends Immunol. 2002;23:130-135.
24. ZhengL,HeM,LongM,BlomgranR, StendahlO.Pathogen-induced apoptotic neutrophils express heat shock proteins and elicit activation ofhuman macrophages.J Immunol. 2004; 173:6319-6326
25. Low QE, Drugea IA, Duffner LA, et al. Wound healing in MIP-1alpha( - / -) and MCP-1(-/ -) mice. Am J Pathol. 2001;159:457-463.
26. Wu L, Yu YL, Galiano RD, Roth SI, Mustoe TE. Macrophage colony-stimulating factor accelerates wound healing and up-regulates TGF-beta1 mRNA levels through tissue macrophages. J Surg Res. 1997;72:162-169.
27. Plowden J, Renshaw-Hoelscher M, Engleman C, Katz J, Sambhara S. Innate immunity in aging: Impact on macrophage function. Aging Cell 2004;3:161-167.
28. Loyola W, Gaziri DA, Gaziri LC, Felipe I. Concanavalin A enhances phagocytosis and killing of Candida albicans by mice peritoneal neutrophils and macrophages. FEMS Immunol Med Microbiol. 2002;33:201-208.
29. Portera CA, Love EJ, Memore L, et al. Effect of macrophage stimulation on collagen biosynthesis in the healing wound. Am Surg. 1997;63:125-131.
30. Ladin D. Becaplermin gel (PDGF-BB) as topical wound therapy. Plastic Surgery Educational Foundation DATA Committee. Plast Reconstr Surg. 2000;105:1230-1231.
31. Nagai MK, Embil JM. Becaplermin: Recombinant platelet derived growth factor, a new treatment for healing diabetic foot ulcers. Exp Opin Biol Ther. 2002;2:211-218.
32. Steed DL, Goslen JB, Holloway GA, Malone JA, Bunt TJ, Webster MW. Randomized prospective double-blind trial in healing chronic diabetic foot ulcers: CT-102 activated platelet supernatant, topical versus placebo. Diabetes Care 1992; 15:1598-1604.
33. de Almeida CJ, Linden R. Phagocytosis of apoptotic cells: A matter of balance. Cell Mol Life Sci. 2005;62:1532-1546.
34. Ferguson MW, O'Kane S. Scar-free healing: From embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci. 2004;359:839-850.
35. WangJ, Jiao H, Stewart TL, et al. Accelerated wound healing in leukocyte-specific, protein 1-deficient mouse is associated with increased infiltration of leukocytes and fibrocytes.JLeu-koc Biol. 2007;82:1554-1563.
36. Gharaee-Kermani M, Phan SH. Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. Curr Pharm Des. 2001;7:1083-1103.
37. Tosi MF. Innate immune responses to infection. J Allergy Clin Immunol. 2005;116:241-249.
38. Underhill DM. Collaboration between the innate immune receptors dectin-1, TLRs, and Nods. Immunol Rev. 2007;219:75-87.
39. Roos A, Xu W, Castellano G, et al. Mini-review: A pivotal role for innate immunity in the clearance of apoptotic cells. Eur J Immunol. 2004;34:921-929.
40. Frasch SC, Henson PM, KaileyJM, et al. Regulation of phospholipid scramblase activity during apoptosis and cell activation by protein kinase Cdelta. J Biol Chem. 2000;275:23065-23073.
41. Zhou Z. New phosphatidylserine receptors: Clearance of apoptotic cells and more. Dev Cell 2007;13:759-760.
42. Kim S, Chung EY, Ma X. Immunological consequences of macrophage-mediated clearance of apoptotic cells. Cell Cycle 2005;4:231-234.
43. Navratil JS, Sabatine JM, Ahearn JM. Apoptosis and immune responses to self. RheumDis ClinNorth Am. 2004;30:193-212.
44. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: Clearance of apoptotic cells regulates immune responses. Nat Rev Immunol. 2002;2:965-975.
45. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. The dorsoventral regulatory gene cassette spätzle/Toll/ cactus controls the potent antifungal response in Drosophila adults. Cell 1996;86:973-983.
46. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783-801.
47. Beutler B, Jiang Z, Georgel P, et al. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol. 2006;24:353-389.
48. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335-376.
49. Doyle SE, O'Connell RM, Miranda GA, et al. Toll-like receptors induce a phagocytic gene program through p38. J Exp Med. 2004;199:81-90.
50. Underhill DM. Macrophage recognition of zymosan particles. J Endotoxin Res. 2003;9:176-180.
51. Macedo L, Pinhal-Enfield G, Alshits V, Elson G, Cronstein BN, Leibovich SJ. Wound healing is impaired in MyD88-deficient mice: A role for MyD88 in the regulation of wound healing by adenosine A2A receptors. Am J Pathol. 2007;171: 1774-1788.
52. Pevsner-Fischer M, Morad V, Cohen-Sfady M, et al. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 2007;109:1422-1432.
53. Girardin SE, Boneca IG, Carneiro LA, et al. Nod1 detects a unique neuropeptide from gram-negative bacterial pepti-doglycan. Science 2003;300:1584-1587.
54. Girardin SE, Boneca IG, Viala J, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem. 2003;278:8869-8872.
55. Matzinger P. Introduction to the series: Danger model of immunity. Scand J Immunol. 2001;54:2-3.
56. Carneiro L, Magalhaes J, Tattoli I, Philpott DJ, Travassos LH. Nod-like proteins in inflammation and disease. J Pathol. 2008; 214:136-148.
57. Fritz JH, Ferrero RL, Philpott DJ, Girardin SE. Nod-like proteins in immunity, inflammation and disease. Nat Immunol. 2006;7:1250-1257.
58. Cox D, Tseng CC, Bjekic G, Greenberg S. A requirement for phosphatidylinositol 3-kinase in pseudopod extension. J Biol Chem. 1999;274:1240-1247.
59. McGreal EP, Miller JL, Gordon S. Ligand recognition by antigen-presenting cell C-type lectin receptors. Curr Opin Immunol. 2005;17:18-24.
60. Herant M, Heinrich V, Dembo M. Mechanics of neutrophil phagocytosis: Experiments and quantitative models. J Cell Sci. 2006;119:1903-1913.
61. Tortorella C, Simone O, Piazzolla G, Stella I, Cappiello V, Antonaci S. Role of phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways in granulocyte mac-rophage-colony-stimulating factor failure to delay fas-induced neutrophil apoptosis in elderly humans. J Gerontol. 2006;61:1111-1118.
62. Accolla RS. Host defense mechanisms against pathogens. Surg Infect (Larchmt.) 2006;7(Suppl 2):S5-S7.
63. Danon D,Kowatch MA, Roth GS. Promotionofwound repair in old mice by local injection of macrophages. Proc Natl Acad Sci USA. 1989;86:2018-2020.
64. Gold LI, Rahman M, Blechman KM, et al. Overview of the role for calreticulin in the enhancement of wound healing through multiple biological effects. J Invest Dermatol Symp Proc. 2006;11:57-65.
65. Johnson JD, Fleshner M. Releasing signals, secretory pathways, and immune function of endogenous extracellular heat shock protein 72. J Leukoc Biol. 2006;79:425-434.
66. Prohászka Z, Singh M, Nagy K, et al. Heat shock protein 70 is a potent activator of the human complement system. Cell Stress Chaperones 2002;7:17-22.
67. Wang R, Kovalchin JT, Muhlenkamp P, Chandawarker RY. Exogenous heat shock protein 70 binds macrophage lipid raft microdomain and stimulates phagocytosis, processing, and MHC-II presentation of antigens. Blood 2006;107: 1636-1642.
68. Harder Y, Contaldo C, Klenk J, Banic A, Jakob SM, Erni D. Improved skin flap survival after local heat preconditioning in pigs. J Surg Res. 2004;119:100-105.
69. Kovalchin JT, Mendonca C, Wagh MS, Wang R, Chandawarker RY. In vivo treatment of mice with heat shock protein, gp 96, improves survival of skin grafts with minor and major antigenic disparity. Transpl Immunol. 2006;15:179-185.
70. Kovalchin JT, Wang R, Wagh MS, Azoulay J, Sanders M, Chandawarker RY. In vivo delivery of heat shock protein
71. accelerates wound healing by up-regulating macroph-age-mediated phagocytosis. Wound Repair Regen. 2006;14: 129-137.
72. Todryk S,Melcher AA, Hardwick N, et al. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J Immunol. 1999;163:1398-1408.
73. Wang R, Town T, Gokarn V, Flavell RA, Chandawarker RY. HSP70 enhances macrophage phagocytosis by interaction with lipid raft-associated TLR-7 and upregulating p38 MAPK and PI3K pathways. J Surg Res. 2006;136:58-69.